LRP1 may also partner with the inflammatory mediator NF-kB to elicit eHsp90-mediated colon cancer cell motility [129], while NF-kB was shown to exert pro-motility effects via TLR4 in GBM [141]. The gene discussed is NFKB1; the disease is malignant colon neoplasm.